Results 31 to 40 of about 64,379 (168)

Current Approaches to Support Patients to Withdraw From Image and Performance Enhancing Drugs

Clinical Endocrinology, EarlyView.
ABSTRACT Image and performance‐enhancing drugs (IPEDs) include agents such as androgens, growth hormone, and erythropoietin, which are used to enhance appearance and physical performance. Androgens, also known as anabolic‐androgenic steroids (AAS), are the most used IPEDs worldwide.
Elizabeth Hyams, Bonnie Grant, Richard Quinton, Channa N. Jayasena   +3 more
wiley   +1 more source

Does Metformin combined with Clomiphene Citrate improve fertility related outcomes in Clomiphene resistant women with PCOS: A systematic review

Middle East Fertility Society Journal, 2014
Background: Polycystic Ovary Syndrome (PCOS) is clinically associated with infertility. Many women are resistant to Clomiphene Citrate and the addition of insulin sensitisers may help to overcome this challenge.
Sabraj Gill, Ailsa Gemmell, Rebecca Colleran, Nurhazwani Bt Zanuri, Helen O’Brien, Amudha Poobalan   +5 more
doaj   +1 more source

A rare case of clomiphene citrate induced moderate ovarian hyperstimulation syndrome [PDF]

, 2016
Clomiphene citrate is an orally active non-steroidal triphenylethylene derivative which is commonly used for ovulation induction. It is considered a safe agent and is rarely associated with ovarian hyperstimulation syndrome.
Kharat-Kapote, Deepali, Dudhwadkar, Ameya, Jhaveri, Rujul, Barhate, Sheetal K., Fonseca, Michelle   +4 more
core   +1 more source

Summarizing the Experiences of Individuals Who Have Obesity or Larger Bodies Seeking Fertility Care: A Scoping Review

Obesity Reviews, EarlyView.
ABSTRACT Females who have larger bodies or obesity may be at an increased risk for experiencing infertility. Problematically, both weight or body size and infertility are stigmatized, harming quality of care. We conducted a scoping review to understand the lived experiences of patients who may be subjected to intersecting stigmas of weight and ...
Brooke J. Hebert, Hanna Randhawa, Virginie Blanchette, Kristi B. Adamo, Angela Alberga, Jean‐Patrice Baillargeon, Marilou Côté, Julia Craig, Ariadne Daniel, Liz Dennett, Nicola Heslehurst, Sarah Nutter, Ian Patton, Helena Piccinini‐Vallis, Ximena Ramos Salas, Katie Wadden, Taniya S. Nagpal   +16 more
wiley   +1 more source

Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks

Experimental Physiology, EarlyView.
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan, Stephanie Cowan, Chau Thien Tay, Lisa J. Moran, Ashley H. Ng   +4 more
wiley   +1 more source

Lifetime Hormonal Exposure and Risk of Lung Cancer in Women: Results From a French Population‐Based Case–Control Study (The WELCA Study)

Cancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background With 2 million new cases annually, lung cancer is among the most frequent and the leading cause of cancer‐related death worldwide. Incidence trends differ by gender, decreasing in men but increasing in women, partly due to later tobacco uptake.
Youssouf Gueye, Emilie Cordina Duverger, Pascal Guénel, Marie Wislez, Jean Trédaniel, Hélène Blons, Pierre Laurent‐Puig, Martine Antoine, Mireille Matrat, Loredana Radoï, Marianne Canonico, WELCA study group, Angelergues Antoine, Arame Alex, Arrondeau Jennifer, Badia Alain, Baud Marie‐Henriette, Bergeron Anne, Boffa Claire, Boudabous Hanene, Bousquet Guilhem, Brosseau Solenn, Burgel Pierre‐Régis, Bylicki Olivier, Cadranel Jacques, Camuset Juliette, Canellas Anthony, Carlier Nicolas, Chaabane Nouha, Chapron Jeanne, Chinet Thierry, Chohra Abdelaziz, Chouahnia Abdelkader, Chouaid Christos, Combe Pierre, Crequit Perrine, Crestani Bruno, De Torcy Marie, Doubre Hélène, Doucet Ludovic, Duchemann Boris, Dumenil Coraline, Dumoulin Jennifer, Dusser Daniel, Epaud Christelle, Fabre Elisabeth, Fallet Vincent, Febvre Michel, Fraboulet Séverine, François Thierry, Friard Sylvie, Gazaniol Claire, Giol Mihaela, Giraud Frédérique, Giraud Philippe, Giraud Violaine, Giroux‐Leprieur Etienne, Gounant Valérie, Hajouji‐Idrissi Linda, Hamard Cécile, Honoré Isabelle, Issoufaly Tesnime, Jabot Laurence, Jagot Jean‐Luc, Jouinot Anne, Jouveshomme Stéphane, Kerleveo Adeline, Khalife Hocquemiller Thérèse, Labrune Sylvie, Lafay Michel, Lavolé Armelle, Le Floch Hervé, Le Maignan Christine, Le Pimpec‐Barthes Françoise, Legras Antoine, Lurie Alain, Margery Jacques, Massiani Marie‐Ange, Métivier Anne‐Cécile, Monnet Claire‐Marie, Monnet Isabelle, Mourtada Leila, Naccache Jean Marc, Naltet Charles, Pailler Marie‐Christine, Parent Florence, Pastre Jean, Pécuchet Nicolas, Pouessel Damien, Pricopi Ciprian, Prosper Michel, Rivaud Elisabeth, Rivière Frédéric, Rosencher Lise, Rousseau Gaëlle, Rozensztajn Nathalie, Ruppert Anne‐Marie, Sahut d'Izarn Marine, Salles Yvan, Salmeron Sergio, Thibault Constance, Vaylet Fabien, Vieira Thibault, Vinas Florent, Zelek Laurent   +104 more
wiley   +1 more source

Co-administration of clomiphene citrate and letrozole in mild ovarian stimulation for POSEIDON Group 4 patients : Supplementary Table 2

, 2021
Co-administration of clomiphene citrate and letrozole in mild ovarian stimulation for POSEIDON Group 4 ...
Huang-Tz Ou (8971331), Ta-Sheng Chen (10830759), Meng-Hsing Wu (10830720), Hsin Ta Lin (10827510), Li-Chung Tsai (10830747)   +4 more
core   +1 more source

Melanoma Cells Exposed to Clomiphene Citrate Respond With Cell Cycle Arrest and Reduced Invasiveness

Journal of Applied Toxicology, Volume 46, Issue 10, Page 3675-3679, October 2026.
ABSTRACT Epidemiological studies have suggested that clomiphene citrate (CC) exposure may increase the risk of malignant melanoma, but mechanisms are unknown. We investigated the effects of CC on melanoma cell line A375. Cells were treated with CC at 2, 20, 200, and 2000 ng/mL, followed by assessment of cell viability and metabolism, cell cycle ...
Thaís S. Ribeiro, Felipe H. S. Silva, Ana Paula G. S. Miranda, Isabella T. Borges, Pedro H. D. M. Prazeres, Marcia C. F. Ferreira, Enio Ferreira, Fernando M. Reis, Helen L. Del Puerto   +8 more
wiley   +1 more source

Histopathological changes in the vagina of rats treated neonatally with clomiphene citrate

, 1997
Clomiphene citrate is a nonsteroid antiestrogen which is widely used in the therapy of receptor-positive estrogen for the induction of ovulation. Clomiphene citrate was given subcutaneously to newly born rats with daily injections of 100 mg/kg for 5 days.
Önen, Abdurrahman, Erdi̇nç, Meral, Deveci, Engin   +2 more
core   +1 more source

Comparative Study between Letrozole versus Clomiphene Citrate in Treatment of Polycystic Ovaries (PCO) [PDF]

Al-Azhar International Medical Journal
Background: Polycystic Ovary Syndrome (PCOS) is probably the most common reason that influences females of childbearing age and regularly prompts barrenness. Aim: To compare Letrozole versus Clomiphene citrate in the treatment of Polycystic ovaries (PCOS)
Shaimaa Abdellatif, Ghada Soror, Shaimaa ELshaarawy   +2 more
doaj   +1 more source